<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Chromobox 7 (CBX7) is a chromobox family protein and a component of the Polycomb repressive complex 1 (PRC1) that extends the lifespan of cultured epithelial cells and can act independently of BMI-1 to repress the INK4a/ARF <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor locus </plain></SENT>
<SENT sid="1" pm="."><plain>To determine whether CBX7 might be oncogenic, we examined its expression pattern in a range of <z:mpath ids='MPATH_458'>normal</z:mpath> human tissues and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples </plain></SENT>
<SENT sid="2" pm="."><plain>CBX7 was expressed at high levels in germinal center lymphocytes and germinal center-derived follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, where elevated expression correlated with high c-Myc expression and a more advanced <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> grade </plain></SENT>
<SENT sid="3" pm="."><plain>By targeting Cbx7 expression to the lymphoid compartment in mice, we showed that Cbx7 can initiate T cell <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e> and cooperate with c-Myc to produce highly aggressive B cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, Cbx7 repressed transcription from the Ink4a/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">Arf</z:e> locus and acted epistatically to the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">Arf</z:e>-p53 pathway during <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>These data identify CBX7 as a chromobox protein causally linked to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development and may help explain the low frequency of INK4a/ARF mutations observed in human follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
</text></document>